347 related articles for article (PubMed ID: 29216782)
1. Reduction in Central Line-Associated Bloodstream Infections Correlated With the Introduction of a Novel Silver-Plated Dressing for Central Venous Catheters and Maintained for 6 Years.
Karlnoski R; Abboud EC; Thompson P; Oxner AZ; Sinnott JT; Marcet JE
J Intensive Care Med; 2019 Jul; 34(7):544-549. PubMed ID: 29216782
[TBL] [Abstract][Full Text] [Related]
2. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial.
Timsit JF; Schwebel C; Bouadma L; Geffroy A; Garrouste-Orgeas M; Pease S; Herault MC; Haouache H; Calvino-Gunther S; Gestin B; Armand-Lefevre L; Leflon V; Chaplain C; Benali A; Francais A; Adrie C; Zahar JR; Thuong M; Arrault X; Croize J; Lucet JC;
JAMA; 2009 Mar; 301(12):1231-41. PubMed ID: 19318651
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
Bonne S; Mazuski JE; Sona C; Schallom M; Boyle W; Buchman TG; Bochicchio GV; Coopersmith CM; Schuerer DJ
J Am Coll Surg; 2015 Sep; 221(3):739-47. PubMed ID: 26199017
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of chlorhexidine patches on central line-associated bloodstream infections in children.
Jitrungruengnij N; Anugulruengkitt S; Rattananupong T; Prinyawat M; Jantarabenjakul W; Wacharachaisurapol N; Chatsuwan T; Janewongwirot P; Suchartlikitwong P; Tawan M; Kanchanabutr P; Pancharoen C; Puthanakit T
Pediatr Int; 2020 Jul; 62(7):789-796. PubMed ID: 32065485
[TBL] [Abstract][Full Text] [Related]
5. Comparison of chlorhexidine impregnated dressing and standard dressing for the prevention of central-line associated blood stream infection and colonization in critically ill pediatric patients: A randomized controlled trial.
Duyu M; Karakaya Z; Yazici P; Yavuz S; Yersel NM; Tascilar MO; Firat N; Bozkurt O; Caglar Mocan Y
Pediatr Int; 2022 Jan; 64(1):e15011. PubMed ID: 34610185
[TBL] [Abstract][Full Text] [Related]
6. Chlorhexidine-silver sulfadiazine- or rifampicin-miconazole-impregnated venous catheters decrease the risk of catheter-related bloodstream infection similarly.
Lorente L; Lecuona M; Jiménez A; Raja L; Cabrera J; Gonzalez O; Diosdado S; Marca L; Mora ML
Am J Infect Control; 2016 Jan; 44(1):50-3. PubMed ID: 26412482
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults.
Timsit JF; Mimoz O; Mourvillier B; Souweine B; Garrouste-Orgeas M; Alfandari S; Plantefeve G; Bronchard R; Troche G; Gauzit R; Antona M; Canet E; Bohe J; Lepape A; Vesin A; Arrault X; Schwebel C; Adrie C; Zahar JR; Ruckly S; Tournegros C; Lucet JC
Am J Respir Crit Care Med; 2012 Dec; 186(12):1272-8. PubMed ID: 23043083
[TBL] [Abstract][Full Text] [Related]
8. Dressings and securement devices for central venous catheters (CVC).
Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD010367. PubMed ID: 26358142
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
[TBL] [Abstract][Full Text] [Related]
10. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
Schuerer DJ; Zack JE; Thomas J; Borecki IB; Sona CS; Schallom ME; Venker M; Nemeth JL; Ward MR; Verjan L; Warren DK; Fraser VJ; Mazuski JE; Boyle WA; Buchman TG; Coopersmith CM
Surg Infect (Larchmt); 2007 Aug; 8(4):445-54. PubMed ID: 17883361
[TBL] [Abstract][Full Text] [Related]
11. The bundle "plus": the effect of a multidisciplinary team approach to eradicate central line-associated bloodstream infections.
Walz JM; Ellison RT; Mack DA; Flaherty HM; McIlwaine JK; Whyte KG; Landry KE; Baker SP; Heard SO;
Anesth Analg; 2015 Apr; 120(4):868-76. PubMed ID: 24149581
[TBL] [Abstract][Full Text] [Related]
12. Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian sites.
Lorente L; Lecuona M; Jiménez A; Lorenzo L; Santacreu R; Ramos S; Hurtado E; Buitrago M; Mora ML
Am J Infect Control; 2015 Jul; 43(7):711-4. PubMed ID: 25934065
[TBL] [Abstract][Full Text] [Related]
13. Use of a 1-piece chlorhexidine gluconate transparent dressing on critically ill patients.
Pfaff B; Heithaus T; Emanuelsen M
Crit Care Nurse; 2012 Aug; 32(4):35-40. PubMed ID: 22855077
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study.
Schwebel C; Lucet JC; Vesin A; Arrault X; Calvino-Gunther S; Bouadma L; Timsit JF
Crit Care Med; 2012 Jan; 40(1):11-7. PubMed ID: 21926570
[TBL] [Abstract][Full Text] [Related]
15. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial.
Rupp ME; Lisco SJ; Lipsett PA; Perl TM; Keating K; Civetta JM; Mermel LA; Lee D; Dellinger EP; Donahoe M; Giles D; Pfaller MA; Maki DG; Sherertz R
Ann Intern Med; 2005 Oct; 143(8):570-80. PubMed ID: 16230723
[TBL] [Abstract][Full Text] [Related]
16. Sustained reduction of catheter-associated bloodstream infections with enhancement of catheter bundle by chlorhexidine dressings over 11 years.
Eggimann P; Pagani JL; Dupuis-Lozeron E; Ms BE; Thévenin MJ; Joseph C; Revelly JP; Que YA
Intensive Care Med; 2019 Jun; 45(6):823-833. PubMed ID: 30997542
[TBL] [Abstract][Full Text] [Related]
17. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial.
Maki DG; Stolz SM; Wheeler S; Mermel LA
Ann Intern Med; 1997 Aug; 127(4):257-66. PubMed ID: 9265424
[TBL] [Abstract][Full Text] [Related]
18. Chlorhexidine-silver sulfadiazine-impregnated venous catheters are efficient even at subclavian sites without tracheostomy.
Lorente L; Lecuona M; Jiménez A; Cabrera J; Santacreu R; Lorenzo L; Raja L; Mora ML
Am J Infect Control; 2016 Dec; 44(12):1526-1529. PubMed ID: 27378009
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.
Veenstra DL; Saint S; Saha S; Lumley T; Sullivan SD
JAMA; 1999 Jan; 281(3):261-7. PubMed ID: 9918482
[TBL] [Abstract][Full Text] [Related]
20. A comparative evaluation of antimicrobial coated versus nonantimicrobial coated peripherally inserted central catheters on associated outcomes: A randomized controlled trial.
Storey S; Brown J; Foley A; Newkirk E; Powers J; Barger J; Paige K
Am J Infect Control; 2016 Jun; 44(6):636-41. PubMed ID: 27240799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
